ArticleBMC palliative care2025
Trends of opioids consumption for cancer patients treated by the palliative care department at the last week of life in a tertiary care center.
Article in BMC palliative care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundPain is one of the most distressing symptoms for cancer patients. It remains a public health problem, and there is a need for better pain management at the societal level.
objectivesThe purpose of this study is to characterize the opioid dosages and its type administered to adult cancer patients during their last week of life and to investigate the factors that may have contributed to it by the palliative care team at King Abdulaziz Medical City in Riyadh, Saudi Arabia.
methodsA retrospective cross-sectional study was performed at the King Abdulaziz Medical City (KAMC), utilizing charts of adult cancer patients admitted to palliative care. We studied the use of opioids in the last week of the patient's life (day 7 before patient's death and day 1 before patient's death). We studied all cancer patients who were admitted to the palliative care department at KAMC and died in the hospital from 1/1/2022 to 1/1/2023 (one year).
resultsThe study included 178 patients who met the inclusion and exclusion criteria. Of our sample, 47.2% were male and 52.8% were female. The average age at death was 67.82(± 14.03) years. The average length of last admission to palliative care department was 22.25(± 14.25) days. The most frequent tumor types were gastrointestinal cancers (30.9%), then pancreatic cancers (12.9%), breast cancers and hepatocellular cancers (10.1% for each one of them). Morphine was the most common opioid prescribed at 32.0% 7-days prior to death and increasing to 37.6% 1-day prior to death. Hydromorphone was second most common opioid prescribed, at 17.4% 7-days prior to death and increasing to 24.2% 1-day prior to death. Using a morphine to hydromorphone conversion ratio of 5:1, the mean opioid equivalent to oral morphine 7 days prior to death was 32.01 mg, and on the day prior to death it was 27.78 mg.
conclusionOur study showed that the use of opioids in palliative inpatient care is common in Saudi Arabia, with morphine and hydromorphone being the most commonly used opioids. Our study results emphasize the need for an individualized approach to palliative care, considering patient-specific factors such as comorbidities and pain management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.